A citation-based method for searching scientific literature

Eduardo De Pablo-Fernandez, Raph Goldacre, Julia Pakpoor, Alastair J Noyce, Thomas T Warner. Neurology 2018
Times Cited: 112



Gang Hu, Pekka Jousilahti, Siamak Bidel, Riitta Antikainen, Jaakko Tuomilehto. Diabetes Care 2007
Times Cited: 291




List of shared articles



Times cited

Diabetes mellitus and Parkinson's disease: dangerous liaisons between insulin and dopamine.
Angela De Iuliis, Ennio Montinaro, Giuseppe Fatati, Mario Plebani, Carlo Colosimo. Neural Regen Res 2022
2

Cardiovascular Risk Factors and Phenoconversion to Neurodegenerative Synucleinopathies in Idiopathic REM Sleep Behavior Disorder.
Sheida Zolfaghari, Natalia Lewandowski, Amelie Pelletier, Seyed Ali Naeimi, Jean-François Gagnon, Marina Brillon-Corbeil, Jacques Y Montplaisir, Ronald B Postuma. J Parkinsons Dis 2022
1

Associations Between Diabetic Retinopathy and Parkinson's Disease: Results From the Catalonian Primary Care Cohort Study.
Didac Mauricio, Bogdan Vlacho, Joan Barrot de la Puente, Xavier Mundet-Tudurí, Jordi Real, Jaime Kulisevsky, Emilio Ortega, Esmeralda Castelblanco, Josep Julve, Josep Franch-Nadal. Front Med (Lausanne) 2022
1


The role of nutrition on Parkinson's disease: a systematic review.
Vittorio Emanuele Bianchi, Laura Rizzi, Fahad Somaa. Nutr Neurosci 2022
0


Fasting plasma glucose variability in midlife and risk of Parkinson's disease: A nationwide population-based study.
H S Chung, J S Lee, J A Kim, E Roh, Y-B Lee, S-H Hong, J H Yu, N H Kim, H J Yoo, J A Seo,[...]. Diabetes Metab 2021
6

Proteostasis of Islet Amyloid Polypeptide: A Molecular Perspective of Risk Factors and Protective Strategies for Type II Diabetes.
Danilo Milardi, Ehud Gazit, Sheena E Radford, Yong Xu, Rodrigo U Gallardo, Amedeo Caflisch, Gunilla T Westermark, Per Westermark, Carmelo La Rosa, Ayyalusamy Ramamoorthy. Chem Rev 2021
51

Type 2 Diabetes as a Determinant of Parkinson's Disease Risk and Progression.
Harneek Chohan, Konstantin Senkevich, Radhika K Patel, Jonathan P Bestwick, Benjamin M Jacobs, Sara Bandres Ciga, Ziv Gan-Or, Alastair J Noyce. Mov Disord 2021
28

Diabetes, insulin and new therapeutic strategies for Parkinson's disease: Focus on glucagon-like peptide-1 receptor agonists.
Carmen M Labandeira, Arturo Fraga-Bau, David Arias Ron, Ana Muñoz, Gema Alonso-Losada, Antonio Koukoulis, Jesus Romero-Lopez, Ana I Rodriguez-Perez. Front Neuroendocrinol 2021
5


α-Synuclein Regulates Peripheral Insulin Secretion and Glucose Transport.
Nadeeja Wijesekara, Rosemary Ahrens, Ling Wu, Tammy Langman, Anurag Tandon, Paul E Fraser. Front Aging Neurosci 2021
3

Diabetes Mellitus and Parkinson's Disease: A Systematic Review and Meta-Analyses.
Klara Komici, Grazia Daniela Femminella, Leonardo Bencivenga, Giuseppe Rengo, Gennaro Pagano. J Parkinsons Dis 2021
1

Two Birds One Stone: The Neuroprotective Effect of Antidiabetic Agents on Parkinson Disease-Focus on Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors.
Kai-Jung Lin, Tzu-Jou Wang, Shang-Der Chen, Kai-Lieh Lin, Chia-Wei Liou, Min-Yu Lan, Yao-Chung Chuang, Jiin-Haur Chuang, Pei-Wen Wang, Jong-Jer Lee,[...]. Antioxidants (Basel) 2021
3

Understanding the links between cardiovascular disease and Parkinson's disease.
Judy Potashkin, Xuemei Huang, Claudia Becker, Honglei Chen, Thomas Foltynie, Connie Marras. Mov Disord 2020
38

Body mass index, diabetes, and the risk of Parkinson's disease.
Su-Min Jeong, Kyungdo Han, Dahye Kim, Sang Youl Rhee, Wooyoung Jang, Dong Wook Shin. Mov Disord 2020
29

Insulin Resistance Promotes Parkinson's Disease through Aberrant Expression of α-Synuclein, Mitochondrial Dysfunction, and Deregulation of the Polo-Like Kinase 2 Signaling.
Chien-Tai Hong, Kai-Yun Chen, Weu Wang, Jing-Yuan Chiu, Dean Wu, Tsu-Yi Chao, Chaur-Jong Hu, Kai-Yin David Chau, Oluwaseun Adebayo Bamodu. Cells 2020
34

Plasma Metabolomic Markers of Insulin Resistance and Diabetes and Rate of Incident Parkinson's Disease.
Samantha Molsberry, Kjetil Bjornevik, Katherine C Hughes, Zhongli Joel Zhang, Sarah Jeanfavre, Clary Clish, Brian Healy, Michael Schwarzschild, Alberto Ascherio. J Parkinsons Dis 2020
4

The Association Between Type 2 Diabetes Mellitus and Parkinson's Disease.
Julia L Y Cheong, Eduardo de Pablo-Fernandez, Thomas Foltynie, Alastair J Noyce. J Parkinsons Dis 2020
41


Diabetes Causes Dysfunctional Dopamine Neurotransmission Favoring Nigrostriatal Degeneration in Mice.
Iara Pérez-Taboada, Samuel Alberquilla, Eduardo D Martín, Rishi Anand, Stefania Vietti-Michelina, Nchimunya N Tebeka, James Cantley, Stephanie J Cragg, Rosario Moratalla, Mario Vallejo. Mov Disord 2020
18


Elucidating the Relationship Between Diabetes Mellitus and Parkinson's Disease Using 18F-FP-(+)-DTBZ, a Positron-Emission Tomography Probe for Vesicular Monoamine Transporter 2.
Yanyan Kong, Haicong Zhou, Hu Feng, Junyi Zhuang, Tieqiao Wen, Chencheng Zhang, Bomin Sun, Jiao Wang, Yihui Guan. Front Neurosci 2020
4


α-Synuclein promotes IAPP fibril formation in vitro and β-cell amyloid formation in vivo in mice.
Marija Mucibabic, Pär Steneberg, Emmelie Lidh, Jurate Straseviciene, Agnieszka Ziolkowska, Ulf Dahl, Emma Lindahl, Helena Edlund. Sci Rep 2020
14

Glycation of α-synuclein amplifies the binding with glyceraldehyde-3-phosphate dehydrogenase.
Pavel Semenyuk, Kseniya Barinova, Vladimir Muronetz. Int J Biol Macromol 2019
9